. Author manuscript; available in PMC: 2010 Jan 29.

Published in final edited form as: Cancer Chemother Pharmacol. 2008 Mar 5;63(1):65. doi: 10.1007/s00280-008-0712-z

Table 4.

Hematological Toxicities Attributed to PI-88 and Docetaxel

PI-88 (mg/day)	Docetaxel (mg/m²)	No. patients (No. of courses)	Bruising at injection site incidence		Thrombocytopenia incidence			Anemia incidence

			G1	G2	G1	G2	G3	G1	G2
106	30	3 (6)	0	0	0	0	0	0	0
140	30	3 (5)	1	0	0	0	0	0	0
190	30	3 (8)	3	0	4	0	0	0	2
250	30	7 (23)	1	0	0	0	1	0	2
Total		16 (42)	5 (12%)		5 (12%)			4 (10%)

G1–G3 represent National Cancer Institute CTC grades 1–3 (version 2.0). The number of cycles in which each toxicity was observed is indicated in the body of the table